Saturday, July 11, 2026

Drug profile · INN

drospirenone + ethinylestradiol

drospirenone + ethinylestradiol (YAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 9
News articles 0
Drug details — drospirenone + ethinylestradiol

Quick answer

drospirenone + ethinylestradiol (YAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN drospirenone + ethinylestradiol
Brand YAZ

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. CLIN-10200-458 Phase 3 · Ipsen · Treatment of moderate to severe glabellar lines
  2. FAMPRIDINE, Placebo 515 Phase 3 · PARItec · Spinocerebellar ataxia
  3. YAZ (SH T00186, BAY86-5300) Phase 3 · Bayer HealthCare Animal · Contraception
  4. FTP-CLIN-01 Phase 2 · Anaxis Pharma · glabellar lines.
  5. ARO-ATXN2 Injection Phase 1 · Arrowhead Pharmaceuticals Ireland · Spinocerebellar Ataxia Type 2
  6. Bilateral Cerebellar deep brain stimulation Phase 1 · Shandong Topscience Biotech · Stroke
  7. Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 Phase 1 · Arrowhead Pharmaceuticals Ireland · spinocerebellar ataxia type 2
  8. TAK-831 Oral Suspension Phase 1 · NEUROCRINE BIOSCIENCES · Schizophrenia, Cerebellar Ataxia

Frequently asked questions

What is drospirenone + ethinylestradiol?

drospirenone + ethinylestradiol (YAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for drospirenone + ethinylestradiol?

YAZ is a marketed brand name for drospirenone + ethinylestradiol. Check FDA Drugs@FDA for the current US label holder and prescribing information.